SUSQUEHANNA INTERNATIONAL GROUP, LLP - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 32 filers reported holding VASCULAR BIOGENICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$37,907
-81.9%
155,358
+19.5%
0.00%
Q2 2022$210,000
-8.3%
130,055
-4.2%
0.00%
Q1 2022$229,000
-69.7%
135,800
-64.7%
0.00%
Q4 2021$756,000
+201.2%
384,400
+213.5%
0.00%
Q3 2021$251,000
-43.5%
122,600
-34.0%
0.00%
Q2 2021$444,000
-35.7%
185,800
-46.2%
0.00%
Q1 2021$691,000
-70.2%
345,500
-71.8%
0.00%
Q4 2020$2,316,000
+7137.5%
1,224,574
+4609.9%
0.00%
Q3 2020$32,000
+146.2%
26,000
+149.9%
0.00%
Q2 2020$13,000
-18.8%
10,406
-13.7%
0.00%
Q1 2020$16,000
-15.8%
12,062
-39.6%
0.00%
Q4 2018$19,000
-34.5%
19,976
+10.4%
0.00%
Q3 2018$29,000
-63.8%
18,100
-50.4%
0.00%
Q2 2018$80,000
-73.6%
36,500
-72.3%
0.00%
Q1 2018$303,000
-72.0%
131,832
-13.5%
0.00%
Q4 2017$1,082,000
+326.0%
152,367
+266.3%
0.00%
Q3 2017$254,000
+120.9%
41,591
+61.1%
0.00%
Q2 2017$115,000
-68.0%
25,812
-62.5%
0.00%
Q3 2016$359,000
+508.5%
68,836
+439.7%
0.00%
Q2 2016$59,000
+13.5%
12,755
-15.0%
0.00%
Q1 2016$52,00015,0000.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$5,108,0001.37%
Ikarian Capital, LLC 790,838$1,558,0000.23%
Telemetry Investments, L.L.C. 70,000$138,0000.18%
PVG ASSET MANAGEMENT CORP 12,365$24,359,0000.09%
DLD Asset Management, LP 425,000$837,0000.04%
Phoenix Holdings Ltd. 1,020,000$2,009,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$32,0000.03%
ARK Investment Management 1,330,206$2,621,0000.01%
Harel Insurance Investments & Financial Services Ltd. 194,000$382,0000.01%
Total Clarity Wealth Management, Inc. 4,000$8,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders